Table 3: Comparison of demographic, physical and clinical characteristics and treatment modalities of patients with TOA (n = 193).
Parameter |
Medical Threatment (n = 68) |
Surgical Threatment (n = 125) |
P value |
Age (year) |
39.1 ± 8.4 (22-64) |
40.9 ± 6.6 (23-56) |
0.084 |
BMI (kg/m2) |
27.3 ± 4.6 (20-41) |
28.4 ± 5.0 (16-44) |
0.263 |
Smoking |
39 (%57.3) |
65 (%52) |
0.172 |
IUD |
29 (%42.6) |
63 (%52.9) |
0.007 |
Past history of PID |
4 (%5.8) |
9 (%7.2) |
0.469 |
Cesarean delivery |
16 (%23.5) |
32 (%25.6) |
0.347 |
Prior pelvic surgery |
24 (%35.2) |
43 (%34.4) |
0.352 |
Prior intrauterine surgery |
26 (%38.2) |
50 (%40) |
0.329 |
Length of stay in hospital (days) |
11.3 ± 4.2 (2-20) |
15.2 ± 4.9 (3-30) |
0.318 |
White cell (/mm3) |
11,884 ± 4,684 |
14,254 ± 5,182 |
0.004 |
CRP (mg/L) |
85.9 ± 78.8 |
152.3 ± 105.5 |
0.000 |
Abscess location · Unilateral · Bilateral |
n (%) 50 (%73.5) 18 (%26.5) |
n (%) 91 (%72.8) 34 (%27.2) |
0.002 |
Largest abscess size (mm) |
60.7 ± 21.4 (33-123) |
70.5 ± 18.7 (30-133) |
0.021 |
Recurrence |
8 (%11.7) |
4 (%3.2) |
0.031 |
CRP: C-Reactive Protein; PID: Pelvic Inflammatory Disease; IUD: Intrauterine Device; BMI: Body Mass Index